We read with deep interest the report by Tepasse and colleagues1 , concerning two cases of persisting viremia in Covid‐19 with fatal outcome. Whilst SARS‐CoV‐2 infection in the early stages of infection has been well described, less is known about the development of antibodies to SARS‐CoV‐2, clearance of RNA shedding and clinical outcome of COVID‐19.